Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leishmania donovani | 10 | 2021 | 68 | 2.960 |
Why?
|
| Leishmaniasis, Visceral | 10 | 2021 | 100 | 2.860 |
Why?
|
| Antiprotozoal Agents | 4 | 2021 | 95 | 1.100 |
Why?
|
| Electron Transport Complex III | 1 | 2019 | 31 | 0.670 |
Why?
|
| Amino Acids | 1 | 2019 | 1714 | 0.430 |
Why?
|
| Mice, Inbred BALB C | 8 | 2021 | 6241 | 0.380 |
Why?
|
| Macrophages | 4 | 2020 | 5797 | 0.360 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 977 | 0.300 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4419 | 0.280 |
Why?
|
| Mitochondria | 2 | 2019 | 3672 | 0.270 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2021 | 90 | 0.210 |
Why?
|
| Vero Cells | 2 | 2019 | 486 | 0.190 |
Why?
|
| Interferon-gamma | 2 | 2020 | 3169 | 0.190 |
Why?
|
| Sizofiran | 1 | 2020 | 2 | 0.190 |
Why?
|
| Protozoan Vaccines | 1 | 2020 | 13 | 0.190 |
Why?
|
| Structure-Activity Relationship | 3 | 2021 | 3073 | 0.170 |
Why?
|
| Immune Evasion | 2 | 2020 | 377 | 0.160 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2020 | 706 | 0.160 |
Why?
|
| Molecular Structure | 2 | 2021 | 1889 | 0.160 |
Why?
|
| Cricetinae | 2 | 2019 | 2423 | 0.150 |
Why?
|
| Antigens, Protozoan | 1 | 2020 | 316 | 0.150 |
Why?
|
| Ethylenes | 1 | 2017 | 43 | 0.150 |
Why?
|
| Metronidazole | 1 | 2019 | 233 | 0.150 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2017 | 96 | 0.140 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 262 | 0.140 |
Why?
|
| Interleukin-12 | 1 | 2019 | 578 | 0.140 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 1561 | 0.140 |
Why?
|
| Interleukin-10 | 2 | 2020 | 1185 | 0.140 |
Why?
|
| Spleen | 2 | 2019 | 2298 | 0.130 |
Why?
|
| Drug Design | 1 | 2021 | 1050 | 0.130 |
Why?
|
| Prostaglandin D2 | 1 | 2016 | 108 | 0.130 |
Why?
|
| Pyridones | 1 | 2021 | 819 | 0.130 |
Why?
|
| Adjuvants, Immunologic | 1 | 2020 | 998 | 0.120 |
Why?
|
| Mice | 10 | 2023 | 82045 | 0.120 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 162 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2019 | 1706 | 0.120 |
Why?
|
| Toll-Like Receptors | 1 | 2018 | 582 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2884 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2020 | 3437 | 0.110 |
Why?
|
| Quinolines | 1 | 2019 | 769 | 0.110 |
Why?
|
| Up-Regulation | 2 | 2019 | 4138 | 0.110 |
Why?
|
| Integrins | 1 | 2017 | 845 | 0.100 |
Why?
|
| Cell Communication | 1 | 2019 | 1662 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2021 | 19041 | 0.100 |
Why?
|
| Animals | 12 | 2023 | 169418 | 0.100 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 18388 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 1816 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 10784 | 0.090 |
Why?
|
| Cell Survival | 1 | 2019 | 5801 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2020 | 1986 | 0.080 |
Why?
|
| Dendritic Cells | 1 | 2019 | 2757 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2882 | 0.070 |
Why?
|
| Immunity, Humoral | 2 | 2023 | 613 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2150 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2019 | 23638 | 0.070 |
Why?
|
| Cytokines | 1 | 2019 | 7449 | 0.060 |
Why?
|
| Germinal Center | 1 | 2023 | 379 | 0.050 |
Why?
|
| Mesocricetus | 1 | 2020 | 255 | 0.040 |
Why?
|
| Drug Compounding | 1 | 2020 | 243 | 0.040 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 199 | 0.040 |
Why?
|
| Cell Differentiation | 3 | 2023 | 11674 | 0.040 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 76 | 0.040 |
Why?
|
| STAT1 Transcription Factor | 1 | 2018 | 343 | 0.030 |
Why?
|
| Amphotericin B | 1 | 2016 | 143 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2016 | 153 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 302 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2298 | 0.030 |
Why?
|
| Cell Line | 2 | 2020 | 15609 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 815 | 0.030 |
Why?
|
| Immunity | 1 | 2019 | 1002 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 2216 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1465 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2023 | 3472 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2232 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2018 | 2944 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2018 | 2491 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 2465 | 0.020 |
Why?
|
| Vaccination | 1 | 2020 | 3434 | 0.020 |
Why?
|
| Kidney | 1 | 2023 | 7064 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 4861 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8332 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 4362 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3826 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2023 | 12174 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10273 | 0.010 |
Why?
|
| Rats | 1 | 2019 | 23839 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9623 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13655 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7575 | 0.010 |
Why?
|
| Apoptosis | 1 | 2016 | 9526 | 0.010 |
Why?
|
| Humans | 2 | 2023 | 768451 | 0.010 |
Why?
|
| Female | 4 | 2019 | 396943 | 0.010 |
Why?
|
| Male | 3 | 2020 | 364781 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 65409 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_